Ishikawa M, Shibata T, Kataoka T, Takekuma M, et al. Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinom Int J Gynecol Cancer 2023;33:692-700.
PMID: 36997229